In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus

被引:0
|
作者
Hiroyuki Kishimoto
Toru Kojima
Yuichi Watanabe
Shunsuke Kagawa
Toshiya Fujiwara
Futoshi Uno
Fuminori Teraishi
Satoru Kyo
Hiroyuki Mizuguchi
Yuuri Hashimoto
Yasuo Urata
Noriaki Tanaka
Toshiyoshi Fujiwara
机构
[1] Okayama University Graduate School of Medicine,Division of Surgical Oncology, Department of Surgery
[2] Dentistry and Pharmaceutical Sciences,Department of Obstetrics and Gynecology
[3] 2-5-1 Shikata-cho,undefined
[4] Center for Gene and Cell Therapy,undefined
[5] Okayama University Hospital,undefined
[6] 2-5-1 Shikata-cho,undefined
[7] Oncolys BioPharma,undefined
[8] Inc.,undefined
[9] 3-16-33 Roppongi,undefined
[10] Minato-ku,undefined
[11] Kanazawa University School of Medicine,undefined
[12] 13-1 Takara-machi,undefined
[13] Laboratory of Gene Transfer and Regulation,undefined
[14] National Institute of Biomedical Innovation,undefined
[15] 7-6-8 Saito-Asagi,undefined
来源
Nature Medicine | 2006年 / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Currently available methods for detection of tumors in vivo such as computed tomography and magnetic resonance imaging are not specific for tumors. Here we describe a new approach for visualizing tumors whose fluorescence can be detected using telomerase-specific replication-competent adenovirus expressing green fluorescent protein (GFP) (OBP-401). OBP-401 contains the replication cassette, in which the human telomerase reverse transcriptase (hTERT) promoter drives expression of E1 genes, and the GFP gene for monitoring viral replication. When OBP-401 was intratumorally injected into HT29 tumors orthotopically implanted into the rectum in BALB/c nu/nu mice, para-aortic lymph node metastasis could be visualized at laparotomy under a three-chip color cooled charged-coupled device camera. Our results indicate that OBP-401 causes viral spread into the regional lymphatic area and selectively replicates in neoplastic lesions, resulting in GFP expression in metastatic lymph nodes. This technology is adaptable to detect lymph node metastasis in vivo as a preclinical model of surgical navigation.
引用
收藏
页码:1213 / 1219
页数:6
相关论文
共 50 条
  • [41] A highly sensitive detection system of genetic alterations in circulating tumor cells using a telomerase-specific replication-competent adenovirus
    Shigeyasu, Kunitoshi
    Hashimoto, Yuuri
    Morikawa, Tatsuya
    Mori, Yoshiko
    Sun, Dong-Sheng
    Kagawa, Shunsuke
    Uno, Futoshi
    Tazawa, Hiroshi
    Nagasaka, Takeshi
    Kyo, Satoru
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2012, 72
  • [42] ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
    Ries, S
    Korn, WM
    BRITISH JOURNAL OF CANCER, 2002, 86 (01) : 5 - 11
  • [43] ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
    S Ries
    W M Korn
    British Journal of Cancer, 2002, 86 : 5 - 11
  • [44] Selective GFP labeling of cancer with a telomerase-specific adenovirus (OBP-401) to report future recurrence after resection
    Kishimoto, Hiroyuki
    Aki, Ryoichi
    Urata, Yasuo
    Bouvet, Michael
    Momiyama, Masashi
    Tanaka, Noriaki
    Fujiwara, Toshiyoshi
    Hoffman, Robert M.
    CANCER RESEARCH, 2011, 71
  • [45] Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer
    W Zhou
    S Dai
    H Zhu
    Z Song
    Y Cai
    J B Lee
    Z Li
    X Hu
    B Fang
    C He
    X Huang
    Gene Therapy, 2017, 24 : 199 - 207
  • [46] Circulating tumor cells using hTERT-specific replication-selective adenovirus in patients with soft tissue sarcoma
    Matsuo, Toshihiro
    Deie, Masataka
    Sugita, Takashi
    Shimose, Shoji
    Urata, Yasuo
    Wakao, Norimitsu
    Kawanami, Katsuhisa
    Ochi, Mitsuo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03): : 5742 - 5748
  • [47] Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer
    Zhou, W.
    Dai, S.
    Zhu, H.
    Song, Z.
    Cai, Y.
    Lee, J. B.
    Li, Z.
    Hu, X.
    Fang, B.
    He, C.
    Huang, X.
    GENE THERAPY, 2017, 24 (04) : 199 - 207
  • [48] Combination therapy of telomerase-specific oncolytic adenovirus and zoledronic acid in human osteosarcoma cells
    Yamakawa, Yasuaki
    Hasei, Joe
    Tazawa, Hiroshi
    Omori, Toshinori
    Osaki, Shuhei
    Sasaki, Tsuyoshi
    Yoshida, Aki
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2014, 74 (19)
  • [49] Clinical Application of Telomerase-Specific Oncolytic Adenovirs to Ex Vivo Biological Imaging of Human Circulating Tumor Cells
    Uno, Futoshi
    Hashimoto, Yuuri
    Kojima, Toru
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    Urata, Yasuo
    Tanaka, Noriaki
    Fujiwara, Toshiyoshi
    MOLECULAR THERAPY, 2009, 17 : S237 - S237
  • [50] Telomerase-specific oncolytic adenovirus amplifies immunogenic effects with anti-PD1 antibody
    Hashimoto, Masashi
    Kuroda, Shinji
    Kanaya, Nobuhiko
    Yagi, Chiaki
    Tsumura, Tomoko
    Kumon, Kento
    Kakiuchi, Yoshihiko
    Kikuchi, Satoru
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2021, 112 : 399 - 399